一种可持续的喘诊断方法:通过数据增强,特征选择和增强算法进行分类
Zne-Jung Lee1, Ming-Ren Yang2, Bor-Jiunn Hwang3
1Department of Electronic and Information Engineering, School of Advanced Manufacturing, Fuzhou University, Quanzhou 362200, China.
Diagnostics (Basel, Switzerland)
|April 13, 2024
概括
这项研究引入了用于喘诊断的先进机器学习方法,通过使用特征选择和数据增强来提高准确性. 该方法有效地识别了关键的诊断特征,优于传统技术.
科学领域:
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
- 机器学习应用 机器学习应用
背景情况:
- 在全球范围内,喘影响了超过3亿人,患病率不断增加,死亡率显著.
- 现有的喘诊断方法与小数据集和复杂的功能空间作斗争.
- 先进的数据分析为改善喘诊断提供了潜力.
研究的目的:
- 利用先进的机器学习开发一种可持续和准确的喘诊断方法.
- 解决处理数据数量,质量和复杂性的传统方法的局限性.
- 为了提高诊断准确度,并确定喘检测的关键特征.
主要方法:
- 使用特征选择来确定最相关的诊断指标.
- 采用数据增强来增加喘数据集的大小和弹性.
- 应用了极端梯度提升算法来进行强大的分类.
主要成果:
- 与现有方法相比,拟议的机器学习方法显示出更高的诊断准确性.
- 数据增强有效地缓解了与不平衡的喘数据集相关的问题.
- 确定了医生辅助喘诊断至关重要的五个基本特征.
结论:
- 先进的机器学习策略为喘诊断提供了更有效的方法.
- 功能选择和数据增强是改善诊断性能的关键组成部分.
- 鉴定出来的特征可以帮助临床医生做出更明智的喘诊断.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391


